Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Semaglutide (a GLP-1R monoagonist) achieved mean weight reductions of approximately 1517% in the STEP clinical trial programme (STEP-1, NEJM 2021)
2.5.2 cDNA synthesis and RT-qPCR Reverse transcription was conducted with 40 ng of RNA per sample using the Reverse Transcription Master Mix Kit (Fluidigm Corporation, San Francisco, California, USA), following the manufacturers instructions
If a clinician declines to prescribe, you receive a full refund automatically
ISBN 978-0-8053-6624-2
US$ 20.60
US$ 27.97
US$ 27.28
US$ 25.17
US$ 20.24
US$ 24.53
US$ 25.75
US$ 27.14
